Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Immunotherapy. Ibaraki Prefectural Central Hospital, Kasama, Ibaraki, Japan

Survival: 10.7 months
Toxicity Grade: 2
Treatments: Immunotherapy
Country: Japan
City/State/Province: Kasama, Ibaraki
Hospital: Ibaraki Prefectural Central Hospital
Journal: Link
Date: 8/2007

Patients: This study involved 12 patients with WHO grade IV glioblastoma multiforme. The average age was 50.5 years, ranging from 35-63. Eight of the patients had recurrent disease.

Treatment: All patients were treated with a formalin-fixed tumor vaccine. This type of vaccine is made with tumor tissue removed during surgery and an adjuvant which increases how the immune system to responds to the tumor.

Toxicity: Grade 1 erythema, induration, and swelling of the injection site occurred, as did low-grade fever and fatigue.

Results: The median overall survival was 10.7 months.

Correspondence: Dr. Koji Tsuboi

E-mail to a Friend Email Physician More Information